Pilgrim, Thomas; Rothenbühler, Martina; Kalesan, Bindu; Pulver, Cédric; Stefanini, Giulio G; Zanchin, Thomas; Räber, Lorenz; Stortecky, Stefan; Jung, Simon; Mattle, Heinrich; Moschovitis, Aris; Wenaweser, Peter Martin; Meier, Bernhard; Gsponer, Thomas; Windecker, Stephan; Jüni, Peter (2014). Additive effect of anemia and renal impairment on long-term outcome after percutaneous coronary intervention. PLoS ONE, 9(12), e114846. Public Library of Science 10.1371/journal.pone.0114846
|
Text
Pilgrim PLoSOne 2014.pdf - Published Version Available under License Creative Commons: Attribution (CC-BY). Download (797kB) | Preview |
INTRODUCTION
Anemia and renal impairment are important co-morbidities among patients with coronary artery disease undergoing Percutaneous Coronary Intervention (PCI). Disease progression to eventual death can be understood as the combined effect of baseline characteristics and intermediate outcomes.
METHODS
Using data from a prospective cohort study, we investigated clinical pathways reflecting the transitions from PCI through intermediate ischemic or hemorrhagic events to all-cause mortality in a multi-state analysis as a function of anemia (hemoglobin concentration <120 g/l and <130 g/l, for women and men, respectively) and renal impairment (creatinine clearance <60 ml/min) at baseline.
RESULTS
Among 6029 patients undergoing PCI, anemia and renal impairment were observed isolated or in combination in 990 (16.4%), 384 (6.4%), and 309 (5.1%) patients, respectively. The most frequent transition was from PCI to death (6.7%, 95% CI 6.1-7.3), followed by ischemic events (4.8%, 95 CI 4.3-5.4) and bleeding (3.4%, 95% CI 3.0-3.9). Among patients with both anemia and renal impairment, the risk of death was increased 4-fold as compared to the reference group (HR 3.9, 95% CI 2.9-5.4) and roughly doubled as compared to patients with either anemia (HR 1.7, 95% CI 1.3-2.2) or renal impairment (HR 2.1, 95% CI 1.5-2.9) alone. Hazard ratios indicated an increased risk of bleeding in all three groups compared to patients with neither anemia nor renal impairment.
CONCLUSIONS
Applying a multi-state model we found evidence for a gradient of risk for the composite of bleeding, ischemic events, or death as a function of hemoglobin value and estimated glomerular filtration rate at baseline.